The increasingly popular nicotine pouches pose a lower risk of cancer than cigarettes, U.S. health officials said.

Federal health officials are backing the health benefits of nicotine pouches, ruling that Philip Morris International’s Zyn ...

“The FDA should not be authorizing the sale of any flavored tobacco products ... among the public figures who have embraced Zyn. Philip Morris has stated it does not employ online influencers ...

Morgan Stanley (NYSE:MS) initiated coverage on shares of Philip Morris International Inc. (NYSE:NYSE:PM) shares, bestowing an Overweight rating and establishing a price target of $140. The move ...

The FDA announced it has authorized the marketing of 20 Zyn nicotine pouch products, citing their greater health benefits vs.

The U.S. Food and Drug Administration formally authorized Zyn nicotine pouches for sale after conducting an "extensive ...

Philip Morris International Inc. (NYSE:PM) announced on Thursday that it completed the previously announced sale of its subsidiary Vectura Group Ltd. to Molex Asia Holdings Ltd. The deal terms ...

Philip Morris outperformed the S&P 500 in 2024 ... opinion and is not meant to be a recommendation of the purchase or sale of stock. The investments and strategies discussed within this article ...

Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...

The U.S. Food and Drug Administration (FDA) has officially authorized the sale of Zyn nicotine pouches, a significant ...